Shandong, China

Mingliang Zhao

This inventor holds 1 USPTO granted patent. Top assignee: Ocean University of China. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mingliang Zhao. Retrieved from https://idiyas.com/inventor/mingliang-zhao-cllff2g5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Mingliang Zhao in Nuclear Magnetic Contrast Agents

Introduction

Mingliang Zhao is a prominent inventor based in Shandong, China. He has made significant contributions to the field of medical imaging, particularly in the development of nuclear magnetic contrast agents. His innovative work focuses on enhancing the visualization of lymphatic tissues, which is crucial for diagnosing various lymph system diseases.

Latest Patents

Mingliang Zhao holds a patent for a "Lymph targeting nuclear magnetic contrast agent using brown algae polysaccharide as carrier and preparation method and use thereof." This patent describes a novel contrast agent that utilizes brown algae polysaccharide as a carrier. The agent is designed to improve the binding capacity to lymphoid tissues, allowing for clearer imaging during MRI scans. The introduction of mannose or mannose derivatives as recognition groups enhances the agent's effectiveness in targeting lymphatic tissues. This advancement significantly aids in the detection and diagnosis of lymphatic system diseases.

Career Highlights

Mingliang Zhao is affiliated with the Ocean University of China, where he conducts research and development in the field of medical imaging. His work has led to the creation of a macromolecular contrast agent with excellent water solubility, which is a critical factor in medical applications. The successful visualization of lymph vessels and lymph nodes under MRI scanning represents a major breakthrough in the field.

Collaborations

Mingliang Zhao has collaborated with notable colleagues, including Tao Jiang and Shengbiao Wan. Their combined expertise has contributed to the advancement of research in nuclear magnetic resonance imaging and its applications in medicine.

Conclusion

Mingliang Zhao's innovative work in developing lymph targeting nuclear magnetic contrast agents has the potential to revolutionize the diagnosis of lymphatic system diseases. His contributions to medical imaging are significant and highlight the importance of continued research in this vital area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…